5 Lung Cancer Clinical Trials in Oakland, CA (2026)

Q: How do I join a clinical trial in Oakland?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Oakland research site will contact you.

Recruiting Lung Cancer Studies in Oakland

NCT07361510Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

The purpose of this study is to evaluate the efficacy of Pumitamig versus Pembrolizumab in participants with previously untreated advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%....

Oakland, CAPHASE3750 participantsBristol-Myers Squibb

View Study Details

NCT05061550Recruiting

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

The study is intended to assess the safety and efficacy of perioperative treatment with Durvalumab in combination with Oleclumab, Monalizumab, or AZD0171 and platinum doublet chemotherapy (CTX); or Vo...

Oakland, CAPHASE2630 participantsAstraZeneca

View Study Details

NCT06498635Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclo...

Oakland, CAPHASE3306 participantsNational Cancer Institute (NCI)

View Study Details

NCT06096844Recruiting

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with mono...

Oakland, CAPHASE3304 participantsNational Cancer Institute (NCI)

View Study Details

NCT07473128Recruiting

Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

The goal of this clinical trial is to compare the efficacy and safety of trilaciclib versus placebo in subjects with limited stage small cell lung cancer. The main question it aims to answer is: Does...

Oakland, CAPHASE3120 participantsPharmacosmos A/S

View Study Details

About Lung Cancer Clinical Trials in Oakland

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 5 lung cancer clinical trials recruiting participants in Oakland, CA. These studies are seeking a combined 2,110 participants. Research is being sponsored by Bristol-Myers Squibb, AstraZeneca, National Cancer Institute (NCI) and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Oakland — FAQ

Are there lung cancer clinical trials in Oakland?

Yes, there are 5 lung cancer clinical trials currently recruiting in Oakland, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Oakland?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oakland research site will contact you about next steps.

Are clinical trials in Oakland free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oakland studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 5 active trials in Oakland are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated July 17, 2026 from ClinicalTrials.gov